Chikungunya and Mayaro Viruses Induce Chronic Skeletal Muscle Atrophy Triggered by Pro-Inflammatory and Oxidative

Mariana Oliveira Lopes da Silva1, Camila Menezes Figueiredo1, Rômulo Leão Silva Neris1

  • 1Department of Virology, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.

Insights

Chikungunya and Mayaro viruses cause long-lasting muscle pain. Viral RNA persists in muscle, causing atrophy even after infection clears, highlighting potential therapeutic targets.

Area of Science:

  • Virology
  • Immunology
  • Skeletal Muscle Physiology

Background:

  • Chikungunya (CHIKV) and Mayaro (MAYV) are arthritogenic alphaviruses causing persistent inflammatory muscle-articular disease.
  • The long-term effects of CHIKV and MAYV on skeletal muscle (SkM) and symptom persistence remain poorly understood.
  • Skeletal muscle plays a critical role in the pathogenesis of these viral infections.

Purpose of the Study:

  • To investigate the temporal impact of CHIKV and MAYV infection on skeletal muscle composition, structure, and repair.
  • To elucidate the mechanisms underlying long-term skeletal muscle atrophy following alphavirus infection.
  • To identify potential therapeutic targets for mitigating CHIKV and MAYV-induced muscle pathology.

Main Methods:

  • Temporal investigation of CHIKV and MAYV replication in a wild-type mice model.
  • Utilized molecular, morphological, nuclear magnetic resonance imaging, and histological analyses.
  • Assessed viral RNA persistence, muscle atrophy markers (MuRF1, Atrogin-1), inflammatory mediators (TNF), and oxidative stress (Nrf2).

Main Results:

  • Viral replication and inflammation led to rapid muscle mass loss and reduced fiber cross-sectional area via MuRF1 and Atrogin-1 upregulation.
  • Skeletal muscle atrophy persisted for 30 days post-infection, despite reduced inflammation and viral clearance.
  • Genomic CHIKV and MAYV RNAs were detected in SkM late in infection, with elevated chemokine and anti-inflammatory cytokine expression.
  • TNF neutralization and Nrf2 activation (monomethyl fumarate) reduced atrophy and increased weight gain.

Conclusions:

  • Arthritogenic alphavirus infections can chronically impact skeletal muscle composition and impair muscle repair mechanisms.
  • Persistent viral RNA and inflammatory mediators contribute to long-term muscle atrophy.
  • Targeting TNF and oxidative stress pathways presents a potential therapeutic strategy for alphavirus-induced myopathy.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
905
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.1K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
348
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
705